We are live on ! Find out more
EAM

Exane Asset Management Portfolio holdings

AUM $277M
1-Year Est. Return 26.27%
This Fund
S&P 500
This Quarter Est. Return
-6.33%
1 Year Est. Return
+26.27%
3 Year Est. Return
+77.5%
5 Year Est. Return
+80.92%
10 Year Est. Return
+419.8%
AUM
$170M
AUM Growth
-$149M
Cap. Flow
-$127M
Cap. Flow %
-74.32%
Top 10 Hldgs %
68.38%
Holding
199
New
70
Increased
19
Reduced
16
Closed
92

Top Buys

Rank Stock Value
1
TAK icon
Takeda Pharmaceutical
TAK
+$15.8M
2
TMUS icon
T-Mobile US
TMUS
+$12.1M
3
T icon
AT&T
T
+$12M
4
SHW icon
Sherwin-Williams
SHW
+$7.25M
5
RHT
Red Hat Inc
RHT
+$4.75M

Top Sells

Rank Stock Value
1
QGEN icon
Qiagen
QGEN
+$19.7M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$14.6M
3
BMY icon
Bristol-Myers Squibb
BMY
+$14.3M
4
UBS icon
UBS Group
UBS
+$11.9M
5
GILD icon
Gilead Sciences
GILD
+$11.4M

Sector Composition

Rank Sector Weight
1 Materials 31.17%
2 Communication Services 24.92%
3 Healthcare 19.33%
4 Utilities 7.37%
5 Technology 6.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXC icon
26
Exelon
EXC
$47.3B
$1.16M 0.68%
36,072
– –
OVV icon
27
Ovintiv
OVV
$16.2B
$1.16M 0.68%
+40,000
New +$1.72M
IDTI
28
DELISTED
Integrated Device Technology I
IDTI
$1.13M 0.66%
+23,350
New +$1.1M
NXTM
29
DELISTED
NxStage Medical Inc.
NXTM
$1.1M 0.65%
38,505
-178
-0.5% -$5.06K
AXTA icon
30
Axalta
AXTA
$6.92B
$1.07M 0.63%
45,537
-306,822
-87% -$7.62M
AGR
31
DELISTED
Avangrid, Inc.
AGR
$1.06M 0.62%
21,071
+7,052
+50% +$347K
DBVT
32
DBV Technologies
DBVT
$870M
$899K 0.53%
14,000
+7,500
+115% +$1.21M
CRTO icon
33
Criteo
CRTO
$1.13B
$807K 0.47%
+35,500
New +$795K
CTMX icon
34
CytomX Therapeutics
CTMX
$788M
$755K 0.44%
50,000
+22,100
+79% +$328K
ARRS
35
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$629K 0.37%
+20,590
New +$572K
TMO icon
36
Thermo Fisher Scientific
TMO
$198B
$604K 0.35%
2,700
-700
-21% -$164K
OXY icon
37
Occidental Petroleum
OXY
$54.6B
$478K 0.28%
7,782
-36
-0.5% -$2.53K
FTSV
38
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$424K 0.25%
+27,000
New +$412K
VET icon
39
Vermilion Energy
VET
$1.51B
$348K 0.2%
16,474
-13,176
-44% -$342K
DVA icon
40
DaVita
DVA
$15.2B
$296K 0.17%
+5,753
New +$368K
LUMN icon
41
Lumen
LUMN
$6.47B
$289K 0.17%
+19,060
New +$364K
UBS icon
42
UBS Group
UBS
$173B
$264K 0.15%
21,199
-879,586
-98% -$11.9M
EOG icon
43
EOG Resources
EOG
$74.5B
$262K 0.15%
3,002
+2,563
+584% +$275K
AHL
44
DELISTED
ASPEN Insurance Holding Limited
AHL
$254K 0.15%
+6,051
New +$253K
WCG
45
DELISTED
Wellcare Health Plans, Inc.
WCG
$220K 0.13%
+931
New +$249K
JWN
46
DELISTED
Nordstrom
JWN
$219K 0.13%
+4,705
New +$265K
J icon
47
Jacobs Solutions
J
$15.6B
$219K 0.13%
+4,519
New +$258K
TIF
48
DELISTED
Tiffany & Co.
TIF
$218K 0.13%
+2,704
New +$276K
RL icon
49
Ralph Lauren
RL
$22.6B
$218K 0.13%
+2,104
New +$248K
APTV icon
50
Aptiv
APTV
$12.2B
$218K 0.13%
+3,533
New +$256K
1
2
3 4 5

Similar funds

RCA
Ranch Capital Advisors Sarasota, Florida $277M AUM 22.08% 1-Year Est. Return
TAM
Townsend Asset Management Raleigh, North Carolina $277M AUM 16.26% 1-Year Est. Return
IIA
ICW Investment Advisors Scottsdale, Arizona $277M AUM 12.1% 1-Year Est. Return
TAP
Tounjian Advisory Partners Fort Myers, Florida $277M AUM 21.37% 1-Year Est. Return
TLA
Tanglewood Legacy Advisors Houston, Texas $276M AUM 16.97% 1-Year Est. Return
1NWS
1 North Wealth Services Annapolis, Maryland $277M AUM 15.28% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
EFP
Envision Financial Planning Memphis, Tennessee $276M AUM 10.87% 1-Year Est. Return

Exane Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Exane Asset Management held 199 positions worth $170M, down 47% from $319M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Exane Asset Management withdrew a net $127M in Q4 2018, closing 92 positions and reducing 16 holdings. Its most notable exit was Qiagen, an estimated $19.7M position sold in full.

By sector, the portfolio is most concentrated in Materials at 31% of assets, up from 23% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Exane Asset Management opened a new position in Takeda Pharmaceutical worth $15.7M.

  • Exane Asset Management's largest Q4 2018 buy was Takeda Pharmaceutical: 933,466 shares worth $15.7M.
  • Exane Asset Management added most to T-Mobile US in Q4 2018, an estimated $12.1M increase.
  • Exane Asset Management's biggest Q4 2018 reduction was Alexion Pharmaceuticals, cutting an estimated $14.6M.
  • Exane Asset Management fully exited Qiagen in Q4 2018, selling an estimated $19.7M.
  • Exane Asset Management's ten largest holdings make up 68% of its $170M portfolio in Q4 2018.
  • Exane Asset Management opened 70 new positions and closed 92 in Q4 2018.
  • Exane Asset Management's portfolio value fell 47% quarter-over-quarter to $170M.

Based on Exane Asset Management's 13F filing for Q4 2018, filed 5 Feb 2019.